McLaughlin Sarah A, Ochoa-Frongia Lisa M, Patil Sujata M, Cody Hiram S, Sclafani Lisa M
Department of Breast Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
J Am Coll Surg. 2008 Jan;206(1):76-82. doi: 10.1016/j.jamcollsurg.2007.07.021. Epub 2007 Oct 18.
Frozen-section analysis (FS) of the sentinel lymph node (SLN) is performed to avoid reoperation for axillary lymph node dissection (ALND), but it can miss micrometastatic disease, is labor intensive for the pathologist, and does not alter the number of breast-conservation therapy (BCT) patients needing reoperation for positive margins. The purpose of this study was to determine if eliminating FS would change reoperation rates in BCT patients.
Between January 2004 and December 2005, 1,218 patients had simultaneous BCT and SLN biopsy for invasive breast cancer. FS of the SLN was used selectively at the surgeon's discretion. Clinical and pathologic data were collected.
Overall, 542 of 1,218 (44%) patients had positive margins. FS of the SLN was performed in 931 of 1,218 (76%) patients. In those having FS, the SLN positivity rate was 33% (306 of 931). FS identified the positive SLN in 170 of 306 (56%) patients with positive nodes, allowing for immediate ALND. But 101 of these 170 patients had positive lumpectomy margins; and FS of the SLN saved 69 of 931 (7%) patients a second operation. Of patients not having FS, 48 of 287 (17%) had a positive SLN on final pathology. Only 18 of 48 (those seen on routine hematoxylin and eosin) might have been seen on FS, potentially sparing reoperation. Half of patients not having FS required reexcision for positive margins. FS would have spared reoperation for only 8 of 287 (3%) patients in this group. Overall, of 354 of 1,218 patients with SLN metastases, 170 had immediate ALND and 98 had delayed ALND. Of those having delayed ALND, 68 of 98 also had positive margins.
Among patients having BCT with SLN biopsy, FS identified the positive SLN in 56% of patients with positive SLNs, allowing immediate ALND, and was false negative in 44%. Margin status remains a frequent indication for reoperation in BCT; routine FS analysis of the SLN ultimately saves only a minority of patients a second operation.
前哨淋巴结(SLN)的冰冻切片分析(FS)用于避免腋窝淋巴结清扫术(ALND)的再次手术,但它可能会遗漏微转移疾病,对病理学家来说劳动强度大,并且不会改变因切缘阳性而需要再次手术的保乳治疗(BCT)患者的数量。本研究的目的是确定取消FS是否会改变BCT患者的再次手术率。
在2004年1月至2005年12月期间,1218例患者同时进行了BCT和浸润性乳腺癌的SLN活检。SLN的FS由外科医生酌情选择性使用。收集了临床和病理数据。
总体而言,1218例患者中有542例(44%)切缘阳性。1218例患者中有931例(76%)进行了SLN的FS。在进行FS的患者中,SLN阳性率为33%(931例中的306例)。FS在306例SLN阳性患者中的170例(56%)中识别出阳性SLN,从而可以立即进行ALND。但这170例患者中有101例乳房肿块切除术切缘阳性;SLN的FS为931例患者中的69例(7%)避免了二次手术。在未进行FS的患者中,287例中有48例(17%)最终病理显示SLN阳性。48例中只有18例(那些在常规苏木精和伊红染色中可见的)可能在FS中被发现,有可能避免再次手术。未进行FS的患者中有一半因切缘阳性需要再次切除。在该组中,FS只能为287例患者中的8例(3%)避免再次手术。总体而言,1218例有SLN转移的患者中,170例立即进行了ALND,98例延迟进行了ALND。在延迟进行ALND的患者中,98例中有68例切缘也阳性。
在进行BCT和SLN活检的患者中,FS在56%的SLN阳性患者中识别出阳性SLN,从而可以立即进行ALND,44%为假阴性。切缘状态仍然是BCT再次手术的常见指征;SLN的常规FS分析最终只能为少数患者避免二次手术。